Clinical Trial Update: A Study of BN104 in the Treatment of Acute Leukemia [Phase 1, Phase 2]

View source ↗

Summary

BN104 is being studied in Phase 1/2 trials for acute leukemia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Acute Myeloid Leukemia with Kmt2a Rearrangement
• Acute Myeloid Leukemia with Npm1 Mutation
• Acute Myeloid Leukemia with Nup98 Gene Rearrangement

Drugs mentioned

• BN104

Snippet

Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.) | Conditions: ALL, Adult, AML, Adult | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING